Introducing a novel series of fatty acid analogs, including 2-heptylcyclopropane-1-carboxylic acid (2CP), designed to prevent and disperse harmful oral biofilms. These compounds offer a 12-hour sustained release to maint...
Innovative chitosan microparticles with hydrophobic surfaces offer extended release of hydrophobic drugs for nasal delivery, improving patient compliance by reducing dosing frequency. Ideal for antihistamines and cortico...